3rd Annual Health Outcomes and Pharmacoeconomics Research Conference
|Event Date/Time: Jan 30, 2012||End Date/Time: Jan 31, 2012|
Hear from industry leaders within Bio/Pharmaceutical and Medical Device companies such as: Novartis Pharmaceuticals, Inc., Endo Pharmaceuticals, BD, Abbott, Takeda Pharmaceuticals, EMD Serono, Inc., Baxter Healthcare and many more!
Attending this conference will allow attendees to walk away with key best practices for conducting successful outcomes research and applying pharmacoeconomics deeper into the brand management, product development and commercialization strategies of the Pharmaceutical industry. Attendees will also be provided with useful and practical guidance for outreach to healthcare, payer, provider and policy areas and its impact on the current state of the US healthcare system.
Attending This Conference Will Enable You To:
â€¢ Review pharmacoeconomics and outcomes research strategies
â€¢ Improve current techniques to gain the largest benefit from data
â€¢ Utilize resources to create a sold HEOR team
â€¢ Assess the future of comparative effectiveness research
â€¢ Look into the future of health outcomes techniques and research in changing landscapes
Who Should Attend?
Vice Presidents, Directors and Managers from the Pharmceutical, Medical Device, Biotech, Research and Insurance industries in:
Global Health Outcomes
Pricing and Reimbursement
Patient Reported Outcomes